CyberCube Launches Portfolio Manager Version 6: Unveiling a New Era of Specific, Actionable Cyber Cat Modeling
LONDON–(BUSINESS WIRE)–CyberCube, the leading cyber risk modeling and analytics business, has released the latest version of Portfolio Manager, its catastrophe... Read more.
Europe’s IT, Business Services Market Boosted by AI-Driven Cloud Demand in Q2: ISG Index™
Combined market up 14% in Q2, driven by 34% growth in XaaS Managed services off 4%, as companies limit discretionary spending LONDON–(BUSINESS WIRE)–$III... Read more.
FICO UK Credit Card Market Report: May 2025
Consumers put the brake on credit card spending, but balances continue to track upwards LONDON–(BUSINESS WIRE)–The latest UK credit card data from global... Read more.
Expro Secures Contract With Woodside Energy for Trion Deepwater Project
Expro to deliver advanced tubular running and cementing services for Woodside’s first ultra-deepwater development offshore Mexico. HOUSTON–(BUSINESS WIRE)–Expro... Read more.
Sun European Partners Affiliate Completes Investment in Alton Cars
Sun European continues to grow its business services portfolio. Alton Cars is a leading collision repair provider in the UK. LONDON–(BUSINESS WIRE)–Sun... Read more.
Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
– Both Phase 3 Studies Met all Primary and Secondary Endpoints Demonstrating Statistically Significant Improvements Across Symptoms at All Doses, Building Upon... Read more.
ROYC and Partners Financial Group Announce Strategic Partnership to Deliver Private Markets Investment Solutions Across Central and Eastern Europe
STOCKHOLM–(BUSINESS WIRE)–ROYC, the leading provider of both private markets investment selection and solutions supported by Europe’s leading technology... Read more.
U.S. FDA Approves KERENDIA® (finerenone) to Treat Patients With Heart Failure With Left Ventricular Ejection Fraction ≥40% Following Priority Review
KERENDIA® (finerenone), a non-steroidal mineralocorticoid receptor antagonist (MRA), is the only MRA approved by the U.S. Food and Drug Administration (FDA) for... Read more.
Samsung Bioepis’ European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely Access to Biosimilar Medicines
Despite contributing €56 billion in cost savings across Europe, biosimilars face inadequate and misaligned policies that discourage continued investment in biosimilar... Read more.
Electronics Manufacturing Service Companies Scanfil and MB Elettronica to Join Forces
SIEVI, Finland–(BUSINESS WIRE)–#CircuitBoard–Finnish Scanfil, the largest European stock exchange listed Electronic Manufacturing Service company... Read more.